Prognosis of aphasia in stroke patients early after iv thrombolysis.
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Introduction
Aphasia is diagnosed in 21-38 % [1] [2] [3] [4] of admitted stroke patients at the acute stage. Patients with aphasia often remain disabled despite low baseline NIHSS scores [5] . These patients are increasingly treated with thrombolysis. Retrospective studies showed that patients with mild stroke symptoms and low baseline NIHSS scores may benefit from thrombolysis with low complication rates [6, 7] . On the other hand could it be shown that spontaneous recovery of aphasia as measured by NIHSS occurred in 74% of all and 90 % of patients with mild stroke symptoms after six months [8] . Data regarding outcome of aphasia in the 24 hours window is lacking.
Aim of this observational study was to find out which early clinical benefit can be expected in patients with aphasia receiving iv thrombolysis. Secondly parameter predictive of aphasia outcome were evaluated.
Materials and Methods
Medical records of prospectively collected data of stroke patients treated by iv thrombolysis (0,9 mg rtPA/kg of body weight infused over 60 minutes with 10% of the total dose administered as an initial intravenous bolus dose over 1 minute, maximal dose 90 mg) in the three hours window during a six years period were retrospectively analysed. All patients had common stroke work-up, assessment of stroke risk factors, Carotid ultrasound, 24 hour ECG monitoring and, in most cases transthoracic echocardiography; some patients had transesophageal echocardiography.
Patients with aphasia (scoring at least one point for aphasia on the 3 points scale; 1 point: mild to moderate aphasia, 2 points: severe aphasia, 3 points: mute or global aphasia) according to the initial assessment made before thrombolysis were included in the analyses of this study.
Patients with incomplete NIHSS charts were excluded. Patients who, in the absence of language improvement, after evaluation by a speech therapist had been considered not to be suffering from aphasia were also excluded. Baseline and demographic data was extracted from the local databank (Malmö).
Common risk factors of stroke were analysed and stroke aetiology was classified according to the TOAST classification [9] by an experienced neurologist. Development of neurological symptoms in the selected patients was assessed using the NIHSS-charts. For aphasia, a change of ≥1 point was considered as a significant change in aphasia outcome. Significant change in global neurological symptoms (aphasia excluded) was defined as a total resolution of the neurological deficit or a change of ≥ 4 points. Stroke severity according to NIHHS was subdivided in minor stroke (≤ 7 points), moderate stroke (8-15 points) and major stroke (≥ 16 points). Long-term outcome was evaluated by clinical examination at three months by the modified Rankin scale (mRS).
All patients were examined with a baseline nonenhanced CT and nonenhanced CT 24 hours after treatment, using a multislice CT (SOMATOM Sensation 16, Siemens AG, Forchheim, Germany). The baseline CTs were evaluated by two specialists in Neuroradiology at two different occasions without knowledge of symptoms or the side affected. Images were evaluated regarding the occurrence of early ischemic changes (EICs). In cases of disagreement a joint evaluation by the two readers was performed to reach a consensus about the occurrence of EICs. Measurement of infarct volume was performed on CT 24 hours after treatment using the "Volume" application at a Leonardo workstation (Siemens AG, Medical Solutions, Erlangen, Germany). The volume of every individual infarct was given in cm 3 .
Statistical analyses were performed using SPSS 17. For descriptive purposes means ± SD, median, and percentages were presented. Mann-Whitney or Kruskal Wallis test was used when comparing categorical data with continuous data while Pearson Chi-Square was used when comparing two categorical variables. The statistical significance was set to a p-value <0.05.
Results
During the period 2002-2008, 172 patients were treated by iv thrombolysis. Fifty patients with aphasia according to NIHSS were included in the study. 31 patients were evaluated by a speech therapist. Six patients were excluded because of misdiagnosis and two because the thrombolytic therapy was not completed. 11 (22%) patients had suffered a minor stroke, 17 (34%) patients a moderate stroke and 22 (44%) patients a major stroke. The percentage of patients with atrial fibrillation (AF) (44%) and cardioembolic stroke (52%) was high in our study population, other clinical and demographic data see Table 1 .
The incidence of AF (38% (6/16 pts.) vs. 47% (16/34 pts.)) and cardioembolic stroke (50% (8/16 pts.) vs. 52% (18/34 pts.) was similar in patients who improved vs. those who were unchanged or impaired in their aphasia.
Course of aphasia and global neurological stroke symptoms 24 hours after thrombolysis is shown in Table 3 .
There was statistically significant association between infarct volume and the aphasia score at admission, and at 24 hours after thrombolysis (Kruskal Wallis test, p=0.033, 0.001, and <0.001, respectively). Patients with no aphasia 24 hours after thrombolysis showed an infarct volume of 0.5±1 cm 3 compared with 106±87 cm 3 among patients with aphasia score of 3, Table 4 .
There was also statistically significant correlation between mRS and the aphasia score at 24 hours after thrombolysis (Kruskal Wallis test, p=0.005) but not with aphasia score at admission (Kruskal Wallis test, p=0.225). Patients with no aphasia at 24 hours after thrombolysis had mRS of 1.1±1.7 compared with 4.4±1.8 among patients with aphasia score of 3, see Table 4 and Figure 1 .
There was no statistically significant correlation between the aphasia score at 24 hours after thrombolysis and the age (r=-0.024, p=0.871), gender (Chi-square test, p=0.903), or death at three months (Chi-square test, p=0.235).
Discussion
In our study one third of patients with aphasia improved, while two thirds remained unchanged within 24 hours after iv thrombolysis. Aphasia at 24 hours was correlated to a higher morbidity according to the mRS at three months. In a recent study it could be shown that the course of aphasia might be benign in patients with mild strokes showing an overall improvement of 86%, and a recovery rate up to 90% as measured by NIHSS after six months questioning the net benefit of thrombolysis in these cases. Twenty-eight patients could be followed-up after a mean of five days, and 26 after 6 months with improvement in 86% and resolution in 80% of all cases. Aphasia outcome at the early stage was not given. At 6 months only the pre-stroke mRS score was associated with improvement of aphasia [10] . The short follow-up of our study population can explain the lower improvement rates. Long-term improvement of aphasia is dependant on neuronal reorganisation, pre-morbid mRS score, and speech therapy. As shown by Inatomi et al. the NIHSS is significantly correlated with the presence of aphasia on admission. 46% of the patients improved after 10 days in a cohort of 855 stroke patients of whom a minority received thrombolysis [11] . Atrial fibrillation was present in nearly half of our patients and cardioembolism the most common stroke aetiology, this was previously shown in aphasic patients [11] .
Eleven patients were admitted with a score of = 7 NIHSS. Patients with aphasia show often low baseline NIHSS scores and the proportion of patients with stroke mimics is higher [12] .
This could lead to an eventual exclusion of patients with aphasia supposed to recover more likely. A low baseline NIHSS score is not predictive of proximal cerebral artery occlusion which is a poor prognostic parameter [13] . Cho et al. reported two cases of stroke patients with minor aphasia who received successful iv thrombolysis. Both had additional magnetic resonance angiography with diffusion and perfusion weighted imaging showing a significant mismatch and proximal artery occlusion [14] .
EICs in patients with aphasia treated with thrombolysis were not a predictor of outcome of aphasia. This is in line with studies showing that EICs in unselected stroke patients receiving thrombolysis did not modify treatment response [15, 16] . Studies in selected patients with aphasia are lacking. On the other hand, patients with smaller infarct volumes showed better outcome of aphasia. Infarct volume has been previously shown to correlate with stroke outcome measured according to the mRS at three months among unselected patients treated with thrombolysis [17] .
The evaluation of aphasia according to the NIHSS has received critics because of the crude and semi-quantitative character of the scale that allows no distinction of aphasic symptoms (sensory/motor for example). At the same time is it well-standardized and one of the major diagnostic instruments to guide treatment decisions in the acute setting. Due to the lack of a randomized control group the natural course of aphasia in stroke patients with potential spontaneous recoveries could not be determined. Another limitation is the small number of included patients, especially in the subgroups which makes a further analysis difficult.
Conclusions
EICs were no predictor of aphasia outcome in patients receiving iv thrombolysis, and the occurrence of EIC should not lead to withdrawal from iv thrombolysis.
One third of the patients receiving iv thrombolysis improved in their aphasia within 24 hours, while two thirds remained unchanged. Improvement of aphasia can indicate early reperfusion of language areas. Given the low rates of improvement and the high morbidity of patients with aphasia a close follow-up of speech functions at the acute stage is recommended. This would help to identify patients with failed reperfusion and potential benefit of intra-arterial thrombolysis and/or mechanical thrombectomy 
